5, an Omicron sub-variant of the coronavirus or SARS-Co-V-2. The sub-variant has since been named Eris. About 10 days ago, the World Health Organization designated EG.5 or Eris as a “variant of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Post this deal, Eris will rank third in its dermatology-covered market with a market share of seven per cent. The transaction will be financed through borrowings and will achieve financial closure ...

All the Latest Game Footage and Images from Eris Dysnomia In a world of monsters and peril, Eris finds herself alone with nothing but her trusty scythe. To save herself from the onslaught of ...

The business could have opted for a lift-off date this month but has shifted the plan back to 2025 to complete “final testing ...

To recap: The swell of COVID-19 cases in summer 2023 was fueled by EG.5, unofficially nicknamed “Eris” by some online just as XBB.1.16 before it was nicknamed “Arcturus” — even though the World Health ...

View all information regarding the medicines that are manufactured by Eris (Enzo Biopharma) including its generic drug name, trade name, how to use, the price, and its composition.

ERIS Lifesciences Ltd share price was up by 1.55% from the previous closing price of ₹1,418.10. Who are peers of ERIS Lifesciences Ltd? The peers of ERIS Lifesciences Ltd are Sun Pharmaceuticals ...